Skip to main content
Top
Published in: Annals of Surgical Oncology 9/2011

01-09-2011 | Melanomas

Quality Assurance Parameters and Predictors of Outcome for Ilioinguinal and Inguinal Dissection in a Contemporary Melanoma Patient Population

Authors: Andrew J. Spillane, MD, FRACS, Lauren Haydu, BSCHE, MIPH, William McMillan, FRACS, Jonathan R. Stretch, D Phil (Oxon), FRACS, John F. Thompson, MD, FRACS

Published in: Annals of Surgical Oncology | Issue 9/2011

Login to get access

Abstract

Background

Regional lymph node dissection (RLND) is currently the most effective therapy for metastatic melanoma in groin lymph nodes. With thorough surgery, RLND lymph node (LN) retrieval numbers have a predictable distribution. Whether patients have inguinal or ilioinguinal dissection varies between institutions. This study was designed to provide LN retrieval parameters for inguinal and ilioinguinal LN dissections, and secondarily, to analyze known predictors for survival outcomes, including LN ratio, i.e., involved/total number LN removed.

Methods

A prospective database was used to identify 189 patients who had 200 groin dissections between July 2002 and February 2008 to derive parameters of LN retrieval. A subgroup of 177 patients who had one RLND was assessed for predictors of survival outcome.

Results

Inguinal dissection had median LN retrieval of 11 (interquartile range, 10–14); 8 LN or more were retrieved in 90% of cases, and 38% of cases had 10 LN or less. Ilioinguinal dissection had median LN retrieval of 21.5 (interquartile range, 17–25); 14 LN or more were retrieved in 90% of cases, and 0 cases had 10 LN or less. The strongest predictors of survival on multivariate analysis were LN ratio, macroscopic LN disease, and ulceration of the primary melanoma. Overall 39% of ilioinguinal dissections had positive pelvic LNs, but only 9.3% of those completed after positive sentinel node biopsy.

Conclusions

Thorough groin RLNDs have a predictable LN yield. LN ratio is the strongest predictor of outcome. Because pelvic LNs are frequently positive ilioinguinal dissection should be considered for all patients, especially those with macroscopic metastases to groin LNs.
Literature
1.
go back to reference Australian Cancer Network. Clinical practice guidelines for the management of melanoma in Australia and New Zealand. Sydney, Australia: Cancer Council Australia/Australian Cancer Network/New Zealand: Ministry of Health, 2008. Australian Cancer Network. Clinical practice guidelines for the management of melanoma in Australia and New Zealand. Sydney, Australia: Cancer Council Australia/Australian Cancer Network/New Zealand: Ministry of Health, 2008.
2.
go back to reference NCCN. NCCN clinical practice guidelines in oncology. Melanoma v.2.2008. National Comprehensive Cancer Network; 2008. NCCN. NCCN clinical practice guidelines in oncology. Melanoma v.2.2008. National Comprehensive Cancer Network; 2008.
3.
go back to reference van der Ploeg IM, Kroon BB, Valdes Olmos RA, Nieweg OE. Evaluation of lymphatic drainage patterns to the groin and implications for the extent of groin dissection in melanoma patients. Ann Surg Oncol. 2009;16(11):2994–9.PubMedCrossRef van der Ploeg IM, Kroon BB, Valdes Olmos RA, Nieweg OE. Evaluation of lymphatic drainage patterns to the groin and implications for the extent of groin dissection in melanoma patients. Ann Surg Oncol. 2009;16(11):2994–9.PubMedCrossRef
4.
go back to reference Spillane AJ, Cheung BL, Stretch JR, et al. Proposed quality standards for regional lymph node dissections in patients with melanoma. Ann Surg. 2009;249(3):473–80.PubMedCrossRef Spillane AJ, Cheung BL, Stretch JR, et al. Proposed quality standards for regional lymph node dissections in patients with melanoma. Ann Surg. 2009;249(3):473–80.PubMedCrossRef
5.
go back to reference Xing Y, Badgwell BD, Ross MI, et al. Lymph node ratio predicts disease-specific survival in melanoma patients. Cancer. 2009;115(11):2505–13.PubMedCrossRef Xing Y, Badgwell BD, Ross MI, et al. Lymph node ratio predicts disease-specific survival in melanoma patients. Cancer. 2009;115(11):2505–13.PubMedCrossRef
6.
go back to reference Rossi CR, Mocellin S, Pasquali S, et al. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma. Ann Surg Oncol. 2008;15(1):310–5.PubMedCrossRef Rossi CR, Mocellin S, Pasquali S, et al. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma. Ann Surg Oncol. 2008;15(1):310–5.PubMedCrossRef
7.
go back to reference Balch CM, Houghton AN, Sober AJ, et al. Cutaneous melanoma, 5th edn. St Louis: Quality Medial Publishing Inc.; 2009. Balch CM, Houghton AN, Sober AJ, et al. Cutaneous melanoma, 5th edn. St Louis: Quality Medial Publishing Inc.; 2009.
8.
go back to reference Spillane AJ, Cheung BL, Winstanley J, Thompson JF. Lymph node ratio provides prognostic information in addition to AJCC N stage in patients with melanoma, even if quality of surgery is standardized. Ann Surg. 2011;253(1):109–15. PubMedCrossRef Spillane AJ, Cheung BL, Winstanley J, Thompson JF. Lymph node ratio provides prognostic information in addition to AJCC N stage in patients with melanoma, even if quality of surgery is standardized. Ann Surg. 2011;253(1):109–15. PubMedCrossRef
9.
go back to reference Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199–206.PubMedCrossRef Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199–206.PubMedCrossRef
10.
go back to reference Spillane AJ, Tucker M, Pasquali S. A pilot study reporting outcomes for melanoma patients of a minimal access ilioinguinal dissection technique based on two incisions. Ann Surg Oncol. 2011;18:970–6 Spillane AJ, Tucker M, Pasquali S. A pilot study reporting outcomes for melanoma patients of a minimal access ilioinguinal dissection technique based on two incisions. Ann Surg Oncol. 2011;18:970–6
11.
go back to reference Delman KA, Kooby DA, Ogan K, et al. Feasibility of a novel approach to inguinal lymphadenectomy: minimally invasive groin dissection for melanoma. Ann Surg Oncol. 2010;17(3):731–7. Delman KA, Kooby DA, Ogan K, et al. Feasibility of a novel approach to inguinal lymphadenectomy: minimally invasive groin dissection for melanoma. Ann Surg Oncol. 2010;17(3):731–7.
12.
go back to reference Chang SB, Askew RL, Xing Y, et al. Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients. Ann Surg Oncol. 2010;17(10):2764–72. Chang SB, Askew RL, Xing Y, et al. Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients. Ann Surg Oncol. 2010;17(10):2764–72.
13.
go back to reference Faries MB, Thompson JF, Cochran A, et al. The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I). Ann Surg Oncol. 2010;17(12):3324–9. Faries MB, Thompson JF, Cochran A, et al. The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I). Ann Surg Oncol. 2010;17(12):3324–9.
14.
go back to reference Wiener M, Acland KM, Shaw HM, et al. Sentinel node positive melanoma patients: prediction and prognostic significance of nonsentinel node metastases and development of a survival tree model. Ann Surg Oncol. 2010;17:1995–2005 Wiener M, Acland KM, Shaw HM, et al. Sentinel node positive melanoma patients: prediction and prognostic significance of nonsentinel node metastases and development of a survival tree model. Ann Surg Oncol. 2010;17:1995–2005
15.
go back to reference Ghaferi AA, Wong SL, Johnson TM, et al. Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma. Ann Surg Oncol. 2009;16(11):2978–84.PubMedCrossRef Ghaferi AA, Wong SL, Johnson TM, et al. Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma. Ann Surg Oncol. 2009;16(11):2978–84.PubMedCrossRef
16.
go back to reference van Akkooi ACJ, de Wilt JHW, Verhoef C, et al. Clinical relevance of melanoma micrometastases (0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Surg Oncol. 2006;17:1578–85. van Akkooi ACJ, de Wilt JHW, Verhoef C, et al. Clinical relevance of melanoma micrometastases (0.1 mm) in sentinel nodes: are these nodes to be considered negative? Ann Surg Oncol. 2006;17:1578–85.
17.
go back to reference Starz H, Balda BR, Kramer KU, et al. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer. 2001;91:2110–21.PubMedCrossRef Starz H, Balda BR, Kramer KU, et al. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer. 2001;91:2110–21.PubMedCrossRef
Metadata
Title
Quality Assurance Parameters and Predictors of Outcome for Ilioinguinal and Inguinal Dissection in a Contemporary Melanoma Patient Population
Authors
Andrew J. Spillane, MD, FRACS
Lauren Haydu, BSCHE, MIPH
William McMillan, FRACS
Jonathan R. Stretch, D Phil (Oxon), FRACS
John F. Thompson, MD, FRACS
Publication date
01-09-2011
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 9/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-011-1755-7

Other articles of this Issue 9/2011

Annals of Surgical Oncology 9/2011 Go to the issue